vs
Side-by-side financial comparison of ASTROTECH Corp (ASTC) and MANGOCEUTICALS, INC. (MGRX). Click either name above to swap in a different company.
ASTROTECH Corp is the larger business by last-quarter revenue ($148.0K vs $94.4K, roughly 1.6× MANGOCEUTICALS, INC.). ASTROTECH Corp runs the higher net margin — -2653.4% vs -2935.1%, a 281.7% gap on every dollar of revenue. On growth, MANGOCEUTICALS, INC. posted the faster year-over-year revenue change (-10.3% vs -43.3%). Over the past eight quarters, MANGOCEUTICALS, INC.'s revenue compounded faster (-33.6% CAGR vs -40.2%).
Astrotech Corporation, formerly Spacehab Inc., is a technology incubator headquartered in Austin, Texas. Astrotech uses technology sourced internally and from research institutions, government laboratories, and universities to fund, manage and sell start-up companies. Astrotech Corporation's subsidiaries provide commercial products and services to NASA, the U.S. Department of Defense, national space agencies, and global commercial customers.
MANGOCEUTICALS, INC. is a men's health and personal care company that develops, manufactures, and distributes science-backed consumer products, including dietary supplements, skincare, and hair care solutions targeted at common male wellness needs. It mainly operates in the U.S. market, selling via direct-to-consumer e-commerce platforms and select retail partners, prioritizing accessible, transparent wellness offerings for adult male consumers.
ASTC vs MGRX — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $148.0K | $94.4K |
| Net Profit | $-3.9M | $-2.8M |
| Gross Margin | 5.4% | 50.3% |
| Operating Margin | -2635.8% | -389.7% |
| Net Margin | -2653.4% | -2935.1% |
| Revenue YoY | -43.3% | -10.3% |
| Net Profit YoY | 2.0% | -42.1% |
| EPS (diluted) | — | $0.38 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $148.0K | $94.4K | ||
| Q3 25 | $297.0K | $84.2K | ||
| Q2 25 | $220.0K | $168.1K | ||
| Q1 25 | $534.0K | $109.3K | ||
| Q4 24 | $261.0K | $105.2K | ||
| Q3 24 | — | $133.4K | ||
| Q2 24 | — | $163.2K | ||
| Q1 24 | — | $214.1K |
| Q4 25 | $-3.9M | $-2.8M | ||
| Q3 25 | $-3.5M | $-7.6M | ||
| Q2 25 | $-2.9M | $-5.4M | ||
| Q1 25 | $-3.6M | $-4.8M | ||
| Q4 24 | $-4.0M | $-1.9M | ||
| Q3 24 | — | $-2.0M | ||
| Q2 24 | — | $-2.4M | ||
| Q1 24 | — | $-2.4M |
| Q4 25 | 5.4% | 50.3% | ||
| Q3 25 | 63.3% | 60.4% | ||
| Q2 25 | 33.6% | 53.5% | ||
| Q1 25 | 44.4% | 56.8% | ||
| Q4 24 | 59.4% | 76.1% | ||
| Q3 24 | — | 62.0% | ||
| Q2 24 | — | 42.8% | ||
| Q1 24 | — | 68.8% |
| Q4 25 | -2635.8% | -389.7% | ||
| Q3 25 | -1190.6% | -8953.5% | ||
| Q2 25 | -1326.4% | -3134.0% | ||
| Q1 25 | -724.2% | -4440.0% | ||
| Q4 24 | -1655.6% | -1594.0% | ||
| Q3 24 | — | -1318.2% | ||
| Q2 24 | — | -1329.1% | ||
| Q1 24 | — | -1105.9% |
| Q4 25 | -2653.4% | -2935.1% | ||
| Q3 25 | -1166.7% | -9042.8% | ||
| Q2 25 | -1331.8% | -3221.6% | ||
| Q1 25 | -680.3% | -4427.4% | ||
| Q4 24 | -1536.0% | -1851.2% | ||
| Q3 24 | — | -1499.0% | ||
| Q2 24 | — | -1465.4% | ||
| Q1 24 | — | -1105.9% |
| Q4 25 | — | $0.38 | ||
| Q3 25 | — | $-0.69 | ||
| Q2 25 | — | $-0.57 | ||
| Q1 25 | — | $-1.29 | ||
| Q4 24 | — | $-0.79 | ||
| Q3 24 | — | $-1.14 | ||
| Q2 24 | — | $-1.37 | ||
| Q1 24 | — | $-1.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.0M | $1.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $15.5M | $15.2M |
| Total Assets | $19.7M | $16.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $7.0M | $1.5M | ||
| Q3 25 | $11.3M | $481.3K | ||
| Q2 25 | $15.1M | $101.0K | ||
| Q1 25 | $18.1M | $76.5K | ||
| Q4 24 | $21.5M | $58.7K | ||
| Q3 24 | — | $73.9K | ||
| Q2 24 | — | $490.2K | ||
| Q1 24 | — | $15.3K |
| Q4 25 | $15.5M | $15.2M | ||
| Q3 25 | $19.1M | $15.7M | ||
| Q2 25 | $22.1M | $19.2M | ||
| Q1 25 | $24.8M | $20.3M | ||
| Q4 24 | $28.1M | $13.9M | ||
| Q3 24 | — | $13.4M | ||
| Q2 24 | — | $13.8M | ||
| Q1 24 | — | $-958.4K |
| Q4 25 | $19.7M | $16.1M | ||
| Q3 25 | $23.2M | $16.5M | ||
| Q2 25 | $27.0M | $20.8M | ||
| Q1 25 | $27.5M | $21.8M | ||
| Q4 24 | $31.0M | $15.4M | ||
| Q3 24 | — | $14.8M | ||
| Q2 24 | — | $15.2M | ||
| Q1 24 | — | $301.4K |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-3.5M | $-1.1M |
| Free Cash FlowOCF − Capex | $-4.0M | — |
| FCF MarginFCF / Revenue | -2671.6% | — |
| Capex IntensityCapex / Revenue | 277.7% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-14.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-3.5M | $-1.1M | ||
| Q3 25 | $-3.9M | $-1.2M | ||
| Q2 25 | $-2.4M | $-1.3M | ||
| Q1 25 | $-3.9M | $-2.3M | ||
| Q4 24 | $-3.0M | $-1.1M | ||
| Q3 24 | — | $-1.2M | ||
| Q2 24 | — | $-1.6M | ||
| Q1 24 | — | $-991.1K |
| Q4 25 | $-4.0M | — | ||
| Q3 25 | $-4.4M | — | ||
| Q2 25 | $-2.7M | — | ||
| Q1 25 | $-3.9M | — | ||
| Q4 24 | $-3.4M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -2671.6% | — | ||
| Q3 25 | -1476.1% | — | ||
| Q2 25 | -1231.4% | — | ||
| Q1 25 | -728.1% | — | ||
| Q4 24 | -1288.5% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 277.7% | — | ||
| Q3 25 | 150.8% | — | ||
| Q2 25 | 158.2% | — | ||
| Q1 25 | 5.1% | — | ||
| Q4 24 | 122.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
